Today’s advancements in medical technology are reshaping how doctors approach the diagnosis and treatment of lung cancer. Although research has made great strides toward increasing the collective knowledge of a variety of diseases and conditions, it appears that lung cancer has been a particular beneficiary.
Already, new devices are diagnosing lung tumors faster, and genetic sequencing has turned up potential medications for lung cancer as well as a gene that may unlock secrets to immunity. And some of these breakthroughs aren’t just speculative in nature — they’ve already been implemented and are helping patients today.
Here is an overview of the recent breakthroughs that are helping doctors win the fight against lung cancer.
A New Gene For Possible Immunity
Researchers have identified a variance in genes that has been linked to a significantly reduced risk of lung cancer. The gene itself is often related to inflammation and immune response, and the discovery of the variant only strengthens the relationship between inflammation, immune response and lung cancer development.
Scientists noted that the variant is believed to result in a 21 to 44 percent reduction in a person’s risk of developing lung cancer. Although researchers insist that more study is needed, and that there does not appear to be a cause-and-effect relationship between the gene variant and lung cancer, it’s possible that more research regarding this abnormality could give scientists clues on how lung cancer can be better treated or even prevented.
Going Deeper For Earlier Detection
Unlike many forms of internal imaging and tumor detection, which use external devices to identify lumps, it turns out the best method of discovery for lung cancer is to probe from the inside out. One high-tech device that has become an industry standard in lung cancer detection is the transesophageal echocardiogram, or TEE. This device uses image-rendering technology similar to an ultrasound, detecting cancerous cells at earlier stages and improving detection rates.
Better yet, the earlier detection increases the survival rates of those diagnosed with lung cancer. Although TEE probe repair and maintenance are required to keep the device effective, it has created a revolutionary change in how doctors identify lung cancer.
Customizable Drugs On The Horizon
If scientists have it right, pharmaceuticals may soon be able to treat lung cancer in pill form. Thanks to huge strides made in DNA sequencing, many experts are hopeful that new research will lead to the advent of lung cancer medications that are tailored to each individual. This customization is achieved by addressing the specific genetic abnormality leading to cancer in every patient.
It’s possible that these new drugs could be available to patients in just a few years, leading to improved treatments and – at long last – medications that will yield significant results in the battle against lung cancer.
While continued advancements can be expected down the road, it’s very uplifting to current lung cancer patients – and those who may develop the mutation in the future – to know that some advancements are already yielding results. Doctors now have a better chance at improving the survival rate of long cancer at its various stages, and early detection could save many more lives. It remains to be seen exactly how these new advancements will change the game for patients with lung cancer, but there’s no doubt that the progress being seen now will only continue to encourage future breakthroughs. For immunity boost please check article about chaga mushroom benefits.